The GIRAFE phase II trial on MVCT-based "volumes of the day" and "dose of the day" addresses when and how to implement adaptive radiotherapy for locally advanced head and neck cancer.

Name: The GIRAFE phase II trial on MVCT-based "volumes of the day" and "dose of the day" addresses when and how to implement adaptive radiotherapy for locally advanced head and neck cancer.
Author: Esteyrie, Vincent

The GIRAFE phase II trial on MVCT-based "volumes of the day" and "dose of the day" addresses when and how to implement adaptive radiotherapy for locally advanced head and neck cancer. — المؤلف: Esteyrie, Vincent — Clinical and translational radiation oncology May 2019

المؤلف: Esteyrie, Vincent
النشر: Clinical and translational radiation oncology May 2019
الوصف: 34-39 p.